Clinical Trial Update: Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating extended-release naltrexone for amphetamine dependence has completed; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amphetamine Dependence

Drugs mentioned

• Naltrexone (extended-release) (Naltrexone)

Snippet

Sponsor: University of Pennsylvania | Conditions: Amphetamine Dependence | Phase 3 | Status: COMPLETED | Results posted: 2014-01-13